| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,437 |
28,351 |
$1.20M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,252 |
13,449 |
$812K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,069 |
3,640 |
$383K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,082 |
2,631 |
$286K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
829 |
806 |
$120K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
6,532 |
6,219 |
$117K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
782 |
726 |
$95K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,951 |
2,758 |
$83K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
1,493 |
1,302 |
$81K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
535 |
419 |
$75K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
895 |
868 |
$74K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,528 |
1,412 |
$70K |
| 36415 |
Collection of venous blood by venipuncture |
7,618 |
6,821 |
$66K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,369 |
1,182 |
$63K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
428 |
178 |
$61K |
| X5622 |
|
1,821 |
1,736 |
$59K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
693 |
680 |
$50K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
767 |
749 |
$44K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,984 |
1,960 |
$44K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,001 |
861 |
$43K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
387 |
116 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,435 |
1,103 |
$34K |
| 99215 |
Prolong outpt/office vis |
372 |
363 |
$33K |
| 80053 |
Comprehensive metabolic panel |
725 |
687 |
$30K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
920 |
665 |
$28K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
629 |
614 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
503 |
446 |
$24K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
382 |
379 |
$24K |
| 86140 |
|
1,110 |
1,047 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,562 |
3,022 |
$21K |
| 92551 |
|
2,989 |
2,945 |
$18K |
| 99188 |
|
2,170 |
2,147 |
$17K |
| 90461 |
|
497 |
490 |
$14K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
370 |
365 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
513 |
462 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
399 |
390 |
$11K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
71 |
65 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
133 |
132 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
116 |
94 |
$9K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
64 |
24 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
219 |
216 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
611 |
595 |
$6K |
| J3490 |
Unclassified drugs |
431 |
215 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
695 |
656 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
148 |
138 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,055 |
928 |
$5K |
| 87081 |
|
305 |
294 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
114 |
111 |
$4K |
| 90686 |
|
1,893 |
1,868 |
$4K |
| 99173 |
|
3,045 |
2,999 |
$4K |
| 91322 |
|
31 |
31 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
41 |
36 |
$4K |
| 11721 |
|
276 |
159 |
$3K |
| 0002A |
|
103 |
103 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
43 |
40 |
$3K |
| 0001A |
|
109 |
101 |
$3K |
| 80061 |
Lipid panel |
56 |
56 |
$3K |
| 96127 |
|
855 |
839 |
$3K |
| 83690 |
|
57 |
54 |
$2K |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
330 |
165 |
$1K |
| 84484 |
|
46 |
37 |
$1K |
| 81025 |
|
36 |
36 |
$1K |
| 90480 |
|
31 |
31 |
$951.95 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
63 |
63 |
$858.72 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
27 |
25 |
$703.09 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20 |
15 |
$596.15 |
| 81003 |
|
43 |
41 |
$432.57 |
| 83735 |
|
12 |
12 |
$418.09 |
| 81001 |
|
28 |
27 |
$417.96 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13 |
12 |
$411.27 |
| 90656 |
|
96 |
96 |
$376.67 |
| 85027 |
|
12 |
12 |
$370.88 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
86 |
86 |
$362.00 |
| 0054A |
|
12 |
12 |
$325.28 |
| 0124A |
|
12 |
12 |
$293.99 |
| G0008 |
Administration of influenza virus vaccine |
14 |
14 |
$97.71 |
| 1111F |
|
810 |
653 |
$0.00 |
| 3044F |
|
52 |
52 |
$0.00 |
| 90651 |
|
12 |
12 |
$0.00 |
| 90734 |
|
17 |
17 |
$0.00 |
| 90670 |
|
37 |
36 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
22 |
14 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| 90648 |
|
53 |
50 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |